Pulmonary Fibrosis

There are more than 200 lung disorders that can lead to pulmonary fibrosis – an irreversible scarring of lung tissue that negatively impacts lung function, quality of life and may become life-threatening.

Three doctors in white lab coats against a pink background

Pulmonary Fibrosis

FIBRONEER™ trials for IPF, other progressive fibrosing ILDs

Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis at Boehringer Ingelheim, discusses the unmet needs of patients with IPF and other forms of progressive fibrosing ILDs and the FIBRONEER™ global clinical program

Read more

Related Press Release

animation of child sitting on couch and smiling with caregiver

First patient enrolled in FIBRONEER™-IPF Phase III trial